Cipro: Potent Antibiotic for Serious Bacterial Infections

Cipro

Cipro

Cipro is an antibiotic in a group of drugs called fluoroquinolones. It is used to treat different types of bacterial infections, e.g. bladder inflammation.
Product dosage: 250mg
Package (num)Per pillPriceBuy
90$0.44$40.00 (0%)🛒 Add to cart
120$0.37$53.33 $44.00 (17%)🛒 Add to cart
180$0.30$80.00 $54.00 (32%)🛒 Add to cart
360
$0.22 Best per pill
$160.00 $79.00 (51%)🛒 Add to cart
Product dosage: 500mg
Package (num)Per pillPriceBuy
60$0.72$43.00 (0%)🛒 Add to cart
90$0.54$64.50 $49.00 (24%)🛒 Add to cart
120$0.46$86.00 $55.00 (36%)🛒 Add to cart
180$0.38$129.00 $68.00 (47%)🛒 Add to cart
270$0.32$193.50 $86.00 (56%)🛒 Add to cart
360
$0.29 Best per pill
$258.00 $104.00 (60%)🛒 Add to cart
Product dosage: 750mg
Package (num)Per pillPriceBuy
30$1.97$59.00 (0%)🛒 Add to cart
60$1.38$118.00 $83.00 (30%)🛒 Add to cart
90$1.18$177.00 $106.00 (40%)🛒 Add to cart
120$1.08$236.00 $130.00 (45%)🛒 Add to cart
180$0.98$354.00 $177.00 (50%)🛒 Add to cart
360
$0.88 Best per pill
$708.00 $317.00 (55%)🛒 Add to cart
Synonyms

Similar products

Cipro (ciprofloxacin) is a broad-spectrum fluoroquinolone antibiotic prescribed for treating serious bacterial infections throughout the body. It works by inhibiting bacterial DNA gyrase and topoisomerase IV enzymes, effectively stopping bacterial replication and growth. This medication is reserved for infections where other antibiotics have failed or are not suitable, making it a critical tool in modern antimicrobial therapy. Proper usage under medical supervision is essential to ensure efficacy and minimize resistance development.

Features

  • Active ingredient: Ciprofloxacin hydrochloride
  • Available forms: Oral tablets (100mg, 250mg, 500mg, 750mg), extended-release tablets (500mg, 1000mg), oral suspension, and intravenous solution
  • Mechanism: Bactericidal action through inhibition of bacterial DNA gyrase and topoisomerase IV
  • Spectrum: Broad activity against Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa
  • Bioavailability: Approximately 70% for oral administration
  • Half-life: About 4 hours in patients with normal renal function

Benefits

  • Effective against multidrug-resistant bacteria where other antibiotics fail
  • Rapid bactericidal action helps control serious infections quickly
  • Excellent tissue penetration throughout the body, including prostate, lungs, and bones
  • Convenient twice-daily dosing for most indications improves compliance
  • Available in multiple formulations for flexible administration
  • Proven efficacy in complicated urinary tract infections, pyelonephritis, and nosocomial pneumonia

Common use

Cipro is indicated for the treatment of various bacterial infections including complicated urinary tract infections, chronic bacterial prostatitis, lower respiratory tract infections, skin and skin structure infections, bone and joint infections, infectious diarrhea, typhoid fever, and complicated intra-abdominal infections (in combination with metronidazole). It is also used for post-exposure prophylaxis and treatment of anthrax inhalation and plague. The medication is particularly valuable for infections caused by Pseudomonas aeruginosa and other difficult-to-treat Gram-negative organisms.

Dosage and direction

Dosage varies significantly based on the type and severity of infection, renal function, and patient characteristics. For most infections in adults with normal renal function, the typical dosage is 250-750mg orally every 12 hours or 400mg IV every 12 hours. Duration of treatment ranges from 7 to 14 days for most infections, though some conditions may require longer therapy. For urinary tract infections: 250-500mg every 12 hours for 7-14 days. For complicated intra-abdominal infections: 500mg every 12 hours with metronidazole for 7-14 days. Tablets should be swallowed whole with a full glass of water, and patients should maintain adequate hydration. Administration should occur at least 2 hours before or 6 hours after antacids, sucralfate, or products containing calcium, iron, or zinc.

Precautions

Patients should be advised to complete the full course of therapy even if symptoms improve. Avoid excessive sunlight or artificial UV light exposure due to photosensitivity risk. Use with caution in patients with known or suspected central nervous system disorders that may predispose to seizures. Monitor for tendon pain, swelling, or inflammation, particularly in elderly patients, those taking corticosteroids, and organ transplant recipients. Renal function should be assessed periodically during treatment, with dosage adjustments for patients with creatinine clearance below 30mL/min. Blood glucose monitoring is recommended in diabetic patients. Caution is advised when operating machinery or driving until the patient’s response to therapy is known.

Contraindications

Cipro is contraindicated in patients with known hypersensitivity to ciprofloxacin, other quinolones, or any component of the formulation. Concurrent administration with tizanidine is contraindicated due to potentially dangerous drug interactions. The medication is contraindicated in patients with a history of tendon disorders related to fluoroquinolone use. Use during pregnancy is generally contraindicated unless the potential benefit justifies the potential risk to the fetus. Breastfeeding is not recommended during treatment due to secretion in human milk. The drug should not be used in pediatric patients except for specific indications (complicated UTI, pyelonephritis, or post-exposure anthrax prophylaxis) where no alternative exists.

Possible side effect

Common side effects (≥1%) include nausea, diarrhea, vomiting, abdominal pain, headache, restlessness, and rash. Less frequent but more serious adverse reactions may include tendonitis and tendon rupture (particularly Achilles tendon), peripheral neuropathy, central nervous system effects (dizziness, confusion, tremors, hallucinations), QT interval prolongation, photosensitivity, hepatic dysfunction, and blood glucose disturbances. Clostridium difficile-associated diarrhea has been reported with use of nearly all antibacterial agents. Hematologic effects may include leukopenia, eosinophilia, and neutropenia. Musculoskeletal effects in children include arthralgia and gait abnormalities.

Drug interaction

Ciprofloxacin may interact with numerous medications including antacids, sucralfate, iron preparations, and zinc supplements (reduced absorption). Concurrent use with theophylline may increase theophylline levels and toxicity risk. Enhanced effects of warfarin require close monitoring of prothrombin time. Nonsteroidal anti-inflammatory drugs may increase the risk of CNS stimulation and seizures. QT-prolonging agents may have additive effects on cardiac repolarization. Cipro may increase serum concentrations of drugs metabolized by CYP1A2 including tizanidine, caffeine, clozapine, olanzapine, and ropinirole. Dose adjustments of hypoglycemic agents may be necessary. Probenecid may decrease renal clearance of ciprofloxacin.

Missed dose

If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Maintaining consistent antibiotic levels is important for effectiveness, so patients should try to adhere to the prescribed dosing schedule as closely as possible. Setting reminders or using pill organizers can help prevent missed doses.

Overdose

Symptoms of overdose may include nausea, vomiting, diarrhea, seizures, confusion, dizziness, tremors, and gastrointestinal irritation. In case of suspected overdose, seek immediate medical attention. Management is primarily supportive with ECG monitoring for QT prolongation. Adequate hydration should be maintained. Hemodialysis or peritoneal dialysis removes only small amounts (less than 10%) of ciprofloxacin. Seizures may require benzodiazepine administration. Acidification of urine increases renal elimination but is not routinely recommended due to risk of crystalluria.

Storage

Store at room temperature (15-30°C or 59-86°F) in a tight, light-resistant container. Keep away from moisture and excessive heat. Do not store in the bathroom. Keep all medications out of reach of children and pets. Oral suspension should be stored at room temperature and discarded after 14 days. Do not freeze the medication. Do not use tablets that are discolored or show signs of deterioration. Proper disposal of unused medication is important to prevent accidental ingestion or environmental contamination.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting, changing, or stopping any medication. The prescribing physician should be aware of the patient’s complete medical history, current medications, and allergies. This medication should only be used for the specific condition for which it was prescribed. Antibiotics should be used appropriately to prevent the development of drug-resistant bacteria.

Reviews

Clinical studies demonstrate ciprofloxacin’s efficacy with success rates of 85-95% for approved indications when used appropriately. Many infectious disease specialists consider it an essential antibiotic for difficult Gram-negative infections. However, concerns about side effects, particularly tendon damage and peripheral neuropathy, have led to more restrictive prescribing guidelines. Patient experiences vary, with many reporting rapid resolution of serious infections, while others describe significant adverse effects. The medical community continues to debate the risk-benefit ratio, emphasizing the importance of reserving ciprofloxacin for situations where alternatives are inadequate or contraindicated.